BioCentury | Mar 31, 2014
Company News

Upsher-Smith, Vertical Pharmaceuticals deal

...equity interesting in Vertical/Trigen (see BioCentury, Jan. 6). Upsher-Smith Laboratories Inc. , Maple Grove, Minn. Vertical Pharmaceuticals LLC...
BioCentury | Jan 6, 2014
Company News

Trigen Laboratories, Vertical Pharmaceuticals Inc., Avista Capital Partners deal

...disclose details, and Vertical and Trigen could not be reached. Trigen Laboratories , Sayreville, N.J. Vertical Pharmaceuticals...
BioCentury | Sep 23, 2013
Company News

Poly Pharmaceuticals, Vertical Pharmaceuticals sales and marketing update

...to disclose details, and Poly could not be reached. Poly Pharmaceuticals Inc. , Quitman, Miss. Vertical Pharmaceuticals...
BioCentury | Nov 7, 2011
Company News

Cipher, Vertical Pharmaceuticals Inc. sales and marketing update

...the U.S. in June (see BioCentury, Sept. 5, 2011). Cipher Pharmaceuticals Inc. (TSX:DND), Mississauga, Ontario Vertical Pharmaceuticals...
BioCentury | Sep 5, 2011
Clinical News

Durela regulatory update

...FDA approved the product for the indication in the U.S., where Cipher and marketing partner Vertical Pharmaceuticals...
Items per page:
1 - 5 of 5
BioCentury | Mar 31, 2014
Company News

Upsher-Smith, Vertical Pharmaceuticals deal

...equity interesting in Vertical/Trigen (see BioCentury, Jan. 6). Upsher-Smith Laboratories Inc. , Maple Grove, Minn. Vertical Pharmaceuticals LLC...
BioCentury | Jan 6, 2014
Company News

Trigen Laboratories, Vertical Pharmaceuticals Inc., Avista Capital Partners deal

...disclose details, and Vertical and Trigen could not be reached. Trigen Laboratories , Sayreville, N.J. Vertical Pharmaceuticals...
BioCentury | Sep 23, 2013
Company News

Poly Pharmaceuticals, Vertical Pharmaceuticals sales and marketing update

...to disclose details, and Poly could not be reached. Poly Pharmaceuticals Inc. , Quitman, Miss. Vertical Pharmaceuticals...
BioCentury | Nov 7, 2011
Company News

Cipher, Vertical Pharmaceuticals Inc. sales and marketing update

...the U.S. in June (see BioCentury, Sept. 5, 2011). Cipher Pharmaceuticals Inc. (TSX:DND), Mississauga, Ontario Vertical Pharmaceuticals...
BioCentury | Sep 5, 2011
Clinical News

Durela regulatory update

...FDA approved the product for the indication in the U.S., where Cipher and marketing partner Vertical Pharmaceuticals...
Items per page:
1 - 5 of 5